Skip to main content

Table 3 Complications of patients with Urexel™ according to individuals and ureter units

From: Initial experience of a novel ureteral silicon-covered metallic mesh stent in malignant ureteric obstruction: a single-center retrospective study

 

N = 12

N = 13

Clavien-Dindo grade I, n (%)

2 (16.7)

2 (15.4)

 Lower urinary tract symptoms

2 (100)

2 (100)

Clavien-Dindo grade II, n (%)

4 (33.3)

5 (38.5)

 Required analgesics

2 (50)

3 (60)

 Pyelonephritis

2 (50)

2 (40)

Clavien-Dindo grade III, n (%)

3 (25)

3 (23.1)

 Stent migration with encrustation

2 (66.7)

2 (66.7)

 Only stent migration

1 (33.3)

1 (33.3)

Clavien-Dindo grade IV or V, n (%)

0 (0)

0 (0)